R M Conry

913 total citations
11 papers, 722 citations indexed

About

R M Conry is a scholar working on Immunology, Molecular Biology and Genetics. According to data from OpenAlex, R M Conry has authored 11 papers receiving a total of 722 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 5 papers in Molecular Biology and 4 papers in Genetics. Recurrent topics in R M Conry's work include Immunotherapy and Immune Responses (5 papers), Virus-based gene therapy research (4 papers) and RNA Interference and Gene Delivery (4 papers). R M Conry is often cited by papers focused on Immunotherapy and Immune Responses (5 papers), Virus-based gene therapy research (4 papers) and RNA Interference and Gene Delivery (4 papers). R M Conry collaborates with scholars based in United States. R M Conry's co-authors include Albert F. LoBuglio, David T. Curiel, L A Sumerel, M. Wright, Richard J. Benjamin, Donghao Lu, D L Barlow, Susan E. Moore, Frosty Loechel and Jeffrey Schlom and has published in prestigious journals such as Nucleic Acids Research, Gene Therapy and PubMed.

In The Last Decade

R M Conry

11 papers receiving 694 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
R M Conry United States	11	476	357	226	129	128	11	722
Mili Gu United States	10	294 0.6×	226 0.6×	135 0.6×	73 0.6×	129 1.0×	16	595
L A Sumerel United States	9	657 1.4×	323 0.9×	489 2.2×	316 2.4×	128 1.0×	10	919
S H Gromkowski United States	13	381 0.8×	674 1.9×	162 0.7×	91 0.7×	92 0.7×	13	1.0k
J Culp United States	12	384 0.8×	444 1.2×	285 1.3×	165 1.3×	97 0.8×	14	828
R. Berg United States	9	472 1.0×	522 1.5×	220 1.0×	54 0.4×	150 1.2×	24	949
Matthias Schroff Germany	16	306 0.6×	316 0.9×	190 0.8×	125 1.0×	78 0.6×	39	685
Alicia Gómez Yafal United States	13	278 0.6×	487 1.4×	212 0.9×	228 1.8×	181 1.4×	15	865
M Ivey-Hoyle United States	13	434 0.9×	176 0.5×	192 0.8×	281 2.2×	149 1.2×	14	787
Gregory Bristol United States	14	293 0.6×	367 1.0×	273 1.2×	183 1.4×	213 1.7×	18	880
Jean Lindenmann Switzerland	12	176 0.4×	567 1.6×	185 0.8×	139 1.1×	79 0.6×	37	840

Countries citing papers authored by R M Conry

Since Specialization

Citations

This map shows the geographic impact of R M Conry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R M Conry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R M Conry more than expected).

Fields of papers citing papers by R M Conry

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R M Conry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R M Conry. The network helps show where R M Conry may publish in the future.

Co-authorship network of co-authors of R M Conry

This figure shows the co-authorship network connecting the top 25 collaborators of R M Conry. A scholar is included among the top collaborators of R M Conry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R M Conry. R M Conry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Conry, R M, M B Khazaeli, Mansoor N. Saleh, et al.. (1999). Phase I trial of a recombinant vaccinia virus encoding carcinoembryonic antigen in metastatic adenocarcinoma: comparison of intradermal versus subcutaneous administration.. PubMed. 5(9). 2330–7. 71 indexed citations

Hj, Baker, et al.. (1998). Humoral and cellular immune responses of dogs immunized with a nucleic acid vaccine encoding human carcinoembryonic antigen. Gene Therapy. 5(7). 865–868. 21 indexed citations

Conry, R M, Stephen White, Patricia N. Fultz, et al.. (1998). Polynucleotide immunization of nonhuman primates against carcinoembryonic antigen.. PubMed. 4(11). 2903–12. 28 indexed citations

Strong, Theresa V., et al.. (1997). Incorporation of β-globin untranslated regions into a Sindbis virus vector for augmentation of heterologous mRNA expression. Gene Therapy. 4(6). 624–627. 23 indexed citations

Loechel, Frosty, et al.. (1997). Immunization with a plasmid expressing pneumococcal surface protein A (PspA) can elicit protection against fatal infection with Streptococcus pneumoniae. Gene Therapy. 4(4). 375–377. 22 indexed citations

Conry, R M, et al.. (1995). A sindbis virus mRNA polynucleotide vector achieves prolonged and high level heterologous gene expressionin vivo. Nucleic Acids Research. 23(9). 1495–1501. 80 indexed citations

Conry, R M, Albert F. LoBuglio, Frosty Loechel, et al.. (1995). A carcinoembryonic antigen polynucleotide vaccine for human clinical use.. PubMed. 2(1). 33–8. 52 indexed citations

Conry, R M, Albert F. LoBuglio, M. Wright, et al.. (1995). Characterization of a messenger RNA polynucleotide vaccine vector.. PubMed. 55(7). 1397–400. 253 indexed citations

Conry, R M, M.B. Khazaeli, Mansoor N. Saleh, et al.. (1995). Phase I trial of an anti-CD19 deglycosylated ricin A chain immunotoxin in non-Hodgkin's lymphoma: effect of an intensive schedule of administration.. PubMed. 18(4). 231–41. 41 indexed citations

10.

Conry, R M, Albert F. LoBuglio, Judy Kantor, et al.. (1994). Immune response to a carcinoembryonic antigen polynucleotide vaccine.. PubMed. 54(5). 1164–8. 96 indexed citations

11.

Ansardi, D C, Zina Moldoveanu, Donna C. Porter, et al.. (1994). Characterization of poliovirus replicons encoding carcinoembryonic antigen.. PubMed. 54(24). 6359–64. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact